NEW YORK, May 9 - Genometrix will work with Nippon Medical School in Tokyo to validate osteoporosis-related SNPs in the Japanese population, the company said Wednesday.

In the study, researchers at Nippon Medical School will screen 100 SNPs against 1,200 clinical patient samples using Genometrix's VistaMorph genotyping technology. They will then use the osteoporosis-related SNPs they find to develop a microarray-based diagnostic and treatment system using Genometrix’s VistaArray microarrays. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.